FGFR2 and Obesity: The aim of this study was to investigate if the Negr1-Fgfr2 pathway was modulated by antidepressant treatment, since this gene has been genetically associated to both MDD and obesity, two co-occurring conditions believed to share common neurobiological alterations [52].